Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9FKR

KAT6A IN COMPLEX WITH SMALL MOLECULE INHIBITOR BAY-184

This is a non-PDB format compatible entry.
Summary for 9FKR
Entry DOI10.2210/pdb9fkr/pdb
DescriptorHistone acetyltransferase KAT6A, ZINC ION, 6-(dimethylamino)-~{N}-(2-phenylphenyl)sulfonyl-1-benzofuran-2-carboxamide, ... (5 entities in total)
Functional Keywordshistone acetyltransferase, small molecule inhibitor, transferase-transferase inhibitor complex, transcription, transferase
Biological sourceHomo sapiens (human)
Total number of polymer chains2
Total formula weight65794.85
Authors
Hillig, R.C.,Puetter, V. (deposition date: 2024-06-04, release date: 2024-11-06, Last modification date: 2024-11-27)
Primary citationTer Laak, A.,Hillig, R.C.,Ferrara, S.J.,Korr, D.,Barak, N.,Lienau, P.,Herbert, S.,Fernandez-Montalvan, A.E.,Neuhaus, R.,Gorjanacz, M.,Puetter, V.,Badock, V.,Bone, W.,Strathdee, C.,Siegel, F.,Schatz, C.,Nowak-Reppel, K.,Doehr, O.,Gradl, S.,Hartung, I.V.,Meyerson, M.,Bouche, L.
Discovery and Characterization of BAY-184: A New Potent and Selective Acylsulfonamide-Benzofuran In Vivo -Active KAT6AB Inhibitor.
J.Med.Chem., 67:19282-19303, 2024
Cited by
PubMed Abstract: KAT6A and KAT6B genes are two closely related lysine acetyltransferases that transfer an acetyl group from acetyl coenzyme A (AcCoA) to lysine residues of target histone substrates, hence playing a key role in chromatin regulation. KAT6A and KAT6B genes are frequently amplified in various cancer types. In breast cancer, the 8p11-p12 amplicon occurs in 12-15% of cases, resulting in elevated copy numbers and expression levels of chromatin modifiers like KAT6A. Here, we report the discovery of a new acylsulfonamide-benzofuran series as a novel structural class for KAT6A/B inhibition. These compounds were identified through high-throughput screening and subsequently optimized using molecular modeling and cocrystal structure determination. The final tool compound, BAY-184 (), was successfully validated in an proof-of-concept study.
PubMed: 39450890
DOI: 10.1021/acs.jmedchem.4c01709
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.69 Å)
Structure validation

248942

PDB entries from 2026-02-11

PDB statisticsPDBj update infoContact PDBjnumon